The Medical Advisor

Key Takeaways (2026) Ivermectin  remains an FDA-approved prescription drug for humans  (e.g., parasitic infections like strongyloidiasis and onchocerciasis).  It is  NOT universally over-the-counter (OTC)  in the U.S.—but  state-level laws are rapidly changing . As of 2025–2026,  some states allow pharmacist dispensing or OTC access , while others still require a prescription. ( Wdam ) Availability is  inconsistent by location , even though there is  no nationwide shortage .  Current Legal Status (U.S., 2026) Federal Level Ivermectin tablets are still classified as a  prescription drug for human use  under FDA regulation. ( MedPath ) Doctors may legally prescribe it  off-label  (common practice in U.S. medicine). State-Level Changes (Major 2025–2026 Shift) Several states have passed or proposed laws to expand access: States allowing easier access Idaho  – OTC availability without prescription Arkansas, Tennessee ...

Low-dose naltrexone (LDN) is generating buzz as a potential treatment for a range of conditions, from chronic pain to autoimmune disorders, offering new hope for patients with difficult-to-manage symptoms. While hailed for its symptom relief, some health experts warn that LDN may not tackle the underlying causes of disease. The question remains: Is this affordable, underutilized drug a breakthrough or merely a temporary fix? A Lifeline Linda Elsgood felt unstoppable. A mother of two and full-time bank manager, she balanced work and family with ease. “I was Wonder Woman. I could do anything,” she told The Epoch Times. But when both her parents fell ill, the stress of caregiving began to take its toll. Soon after, Elsgood began experiencing troubling symptoms: numbness in her leg and face, extreme fatigue, and vision issues. In 2000, she was diagnosed with relapsing-remitting multiple sclerosis (MS). By 2003, the disease had progressed to secondary progressive MS, and her doctors informe...